Baidu
map

Gynecol Endocrinol:α-硫辛酸与甲非那酸联用治疗原发性痛经

2020-07-02 MedSci原创 MedSci原创

原发性痛经是一种常见的妇科疾病,是转诊到妇科门诊的主要原因之一。本研究旨在确定α-硫辛酸(ALA)和甲非那酸及联合用药与安慰剂相比对原发性痛经女孩的影响。

原发性痛经是一种常见的妇科疾病,是转诊到妇科门诊的主要原因之一。本研究旨在确定α-硫辛酸(ALA)和甲非那酸及联合用药与安慰剂相比对原发性痛经女孩的影响。

 

这项双盲、安慰剂对照临床试验纳入居住在卡兹文医科大学宿舍的女生,她们有中度至重度痛经,采用视觉模拟量表(VAS)问卷调查。将参与者随机分为四组(n=100):ALA、甲非那酸、ALA+甲非那酸和安慰剂组。ALA和甲非那酸分别以600mg和250mg的剂量给药。在研究开始和结束时测量疼痛的严重程度。使用SPSS软件(SPSS Inc.,Chicago,IL)进行统计分析。

 

结果显示,虽然甲非那酸能显著降低经期疼痛,但补充600mg ALA较甲非那酸250mg更有效。此外,ALA和甲非那酸的组合使用效果更加明显。

 

综上所述,考虑到补充ALA对原发性痛经患者的止痛效果,可以推荐这种抗氧化剂来缓解这些患者的症状。

 

原始出处:

 

Mojgan YousefiMaria Kavianpour, et al., Effect of Alpha-Lipoic Acid at the Combination With Mefenamic Acid in Girls With Primary Dysmenorrhea: Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Gynecol Endocrinol. 2019 Sep;35(9):782-786. doi: 10.1080/09513590.2019.1590544. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1216121, encodeId=7f6812161215c, content=<a href='/topic/show?id=4b13191349d' target=_blank style='color:#2F92EE;'>#α-硫辛酸#</a>用于<a href='/topic/show?id=8044e114938' target=_blank style='color:#2F92EE;'>#痛经#</a>??, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19134, encryptionId=4b13191349d, topicName=α-硫辛酸), TopicDto(id=71149, encryptionId=8044e114938, topicName=痛经)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:02:39 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846909, encodeId=712b1846909a3, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu May 13 17:08:40 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044144, encodeId=54c120441444f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jul 03 21:08:40 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80746, encryptionId=3fe480e46e5, topicName=联用治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Dec 16 06:08:40 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776470, encodeId=a7e41e764703c, content=<a href='/topic/show?id=5ca93e07266' target=_blank style='color:#2F92EE;'>#原发性痛经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37072, encryptionId=5ca93e07266, topicName=原发性痛经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eecf38942850, createdName=tonychen34, createdTime=Mon May 10 14:08:40 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
    2022-05-01 病毒猎手
  2. [GetPortalCommentsPageByObjectIdResponse(id=1216121, encodeId=7f6812161215c, content=<a href='/topic/show?id=4b13191349d' target=_blank style='color:#2F92EE;'>#α-硫辛酸#</a>用于<a href='/topic/show?id=8044e114938' target=_blank style='color:#2F92EE;'>#痛经#</a>??, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19134, encryptionId=4b13191349d, topicName=α-硫辛酸), TopicDto(id=71149, encryptionId=8044e114938, topicName=痛经)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:02:39 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846909, encodeId=712b1846909a3, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu May 13 17:08:40 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044144, encodeId=54c120441444f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jul 03 21:08:40 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80746, encryptionId=3fe480e46e5, topicName=联用治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Dec 16 06:08:40 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776470, encodeId=a7e41e764703c, content=<a href='/topic/show?id=5ca93e07266' target=_blank style='color:#2F92EE;'>#原发性痛经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37072, encryptionId=5ca93e07266, topicName=原发性痛经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eecf38942850, createdName=tonychen34, createdTime=Mon May 10 14:08:40 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1216121, encodeId=7f6812161215c, content=<a href='/topic/show?id=4b13191349d' target=_blank style='color:#2F92EE;'>#α-硫辛酸#</a>用于<a href='/topic/show?id=8044e114938' target=_blank style='color:#2F92EE;'>#痛经#</a>??, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19134, encryptionId=4b13191349d, topicName=α-硫辛酸), TopicDto(id=71149, encryptionId=8044e114938, topicName=痛经)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:02:39 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846909, encodeId=712b1846909a3, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu May 13 17:08:40 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044144, encodeId=54c120441444f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jul 03 21:08:40 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80746, encryptionId=3fe480e46e5, topicName=联用治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Dec 16 06:08:40 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776470, encodeId=a7e41e764703c, content=<a href='/topic/show?id=5ca93e07266' target=_blank style='color:#2F92EE;'>#原发性痛经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37072, encryptionId=5ca93e07266, topicName=原发性痛经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eecf38942850, createdName=tonychen34, createdTime=Mon May 10 14:08:40 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1216121, encodeId=7f6812161215c, content=<a href='/topic/show?id=4b13191349d' target=_blank style='color:#2F92EE;'>#α-硫辛酸#</a>用于<a href='/topic/show?id=8044e114938' target=_blank style='color:#2F92EE;'>#痛经#</a>??, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19134, encryptionId=4b13191349d, topicName=α-硫辛酸), TopicDto(id=71149, encryptionId=8044e114938, topicName=痛经)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:02:39 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846909, encodeId=712b1846909a3, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu May 13 17:08:40 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044144, encodeId=54c120441444f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jul 03 21:08:40 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80746, encryptionId=3fe480e46e5, topicName=联用治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Dec 16 06:08:40 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776470, encodeId=a7e41e764703c, content=<a href='/topic/show?id=5ca93e07266' target=_blank style='color:#2F92EE;'>#原发性痛经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37072, encryptionId=5ca93e07266, topicName=原发性痛经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eecf38942850, createdName=tonychen34, createdTime=Mon May 10 14:08:40 CST 2021, time=2021-05-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1216121, encodeId=7f6812161215c, content=<a href='/topic/show?id=4b13191349d' target=_blank style='color:#2F92EE;'>#α-硫辛酸#</a>用于<a href='/topic/show?id=8044e114938' target=_blank style='color:#2F92EE;'>#痛经#</a>??, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19134, encryptionId=4b13191349d, topicName=α-硫辛酸), TopicDto(id=71149, encryptionId=8044e114938, topicName=痛经)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:02:39 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846909, encodeId=712b1846909a3, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu May 13 17:08:40 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044144, encodeId=54c120441444f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jul 03 21:08:40 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80746, encryptionId=3fe480e46e5, topicName=联用治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Wed Dec 16 06:08:40 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776470, encodeId=a7e41e764703c, content=<a href='/topic/show?id=5ca93e07266' target=_blank style='color:#2F92EE;'>#原发性痛经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37072, encryptionId=5ca93e07266, topicName=原发性痛经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eecf38942850, createdName=tonychen34, createdTime=Mon May 10 14:08:40 CST 2021, time=2021-05-10, status=1, ipAttribution=)]

相关资讯

PLoS One:α-硫辛酸可用于治疗溶栓的缺血性卒中患者

背景:α-硫辛酸(aLA)是一种强抗氧化剂,常用于治疗糖尿病多发性神经病。以前,研究表明aLA在大鼠脑缺血后有神经修复效果。然而,其对卒中患者的影响仍然是未知的。研究者调查溶栓治疗的急性缺血性卒中(AIS)给予aLA治疗是否有更好的功能预后。方法:在这项回顾性研究中,172例糖尿病和血浆组织型纤溶酶原激活物(tPA)治疗的AIS患者,研究者调查应用aLA与3个月和1年功能结果的相关性。功能结果包括

Cell Death Dis:α-硫辛酸对顺铂诱导的耳毒性的保护和治疗效应评估

顺铂是一种含铂的小分子化合物,并且是一种高效的抗癌药物。然而,在顺铂治疗德癌症患者中发现了严重的副作用,包括肾毒性、神经毒性和耳毒性。这些顺铂诱导的副作用对患者的生活质量有着巨大的影响,包括发展为听力损失的儿科病人的社交发展问题。之前的研究表明了顺铂诱导耳毒性的主要起因时活性氧种类(ROS)的异常积累和氧化胁迫。α-硫辛酸(ALA)是其中一种最为有效的抗氧化物,并且研究表明其参与了细胞抗氧化系统,

Redox Biol:α-硫辛酸利于阿尔茨海默病等神经退行性疾病的治疗!

阿尔茨海默病(AD)是常见的神经退行性疾病,其特征在于由Tau蛋白组成的神经原纤维缠结(NFTs)。

Baidu
map
Baidu
map
Baidu
map